Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
CD22-Directed CAR T-Cell Therapy for Large B-Cell Lymphomas Progressing after CD19-Directed CAR T-Cell Therapy: Continued Durable Remissions at 3-Year Follow-up
CD22-Directed CAR T-Cell Therapy for Large B-Cell Lymphomas Progressing after CD19-Directed CAR T-Cell Therapy: Continued Durable Remissions at 3-Year Follow-up Kramer, A., Baird, J. H., Srinagesh, H., Egeler, E., Levine, K., Brown, A. K., Mavroukakis, S., Cunanan, K., Su, Y., Agarwal, N., Hamilton, M. P., Bharadwaj, S., Arai, S., Johnston, L., Lowsky, R., Meyer, E. H., Negrin, R. S., Rezvani, A. R., Shizuru, J., Mikkilineni, L., Hosoya, H., Shiraz, P., Sidana, S., Weng, W., Kennedy, V. E., Smith, M., Dahiya, S., Davis, K. L., Ramakrishna, S., Schultz, L., Tunuguntla, R., Feldman, S. A., Muffly, L., Mackall, C. L., Miklos, D. B., Frank, M. J. ELSEVIER. 2024: 70-71View details for DOI 10.1182/blood-2024-198544
View details for Web of Science ID 001410860600018